OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of eptinezumab as preventive treatment for episodic/chronic migraine: A systematic review and meta‐analysis
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Showing 9 citing articles:
Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
Andreas Straube, Gregor Broessner, Charly Gaul, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Andreas Straube, Gregor Broessner, Charly Gaul, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Pablo Irimia, Sonia Santos‐Lasaosa, Patricia Pozo‐Rosich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Pablo Irimia, Sonia Santos‐Lasaosa, Patricia Pozo‐Rosich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache
Jason J. Sico, Natasha Antonovich, Jennifer Ballard‐Hernandez, et al.
Annals of Internal Medicine (2024)
Closed Access | Times Cited: 4
Jason J. Sico, Natasha Antonovich, Jennifer Ballard‐Hernandez, et al.
Annals of Internal Medicine (2024)
Closed Access | Times Cited: 4
Documento de consenso de la Sociedad Española de Neurología (SEN), Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atención Primaria (SEMERGEN) y Asociación Española de Migraña y Cefalea (AEMICE) sobre el tratamiento de la migraña
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access | Times Cited: 1
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access | Times Cited: 1
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study
Piero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 672-672
Open Access | Times Cited: 1
Piero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 672-672
Open Access | Times Cited: 1
Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review
Délia Szok, Anett Csáti, László Vécsei, et al.
Life (2023) Vol. 13, Iss. 3, pp. 665-665
Open Access | Times Cited: 2
Délia Szok, Anett Csáti, László Vécsei, et al.
Life (2023) Vol. 13, Iss. 3, pp. 665-665
Open Access | Times Cited: 2
Migrainaren tratamendu profilaktikorako farmakoen eraginkortasunaren azterketa
Nerea Olivares, Aitziber Mendiguren
EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria (2024)
Open Access
Nerea Olivares, Aitziber Mendiguren
EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria (2024)
Open Access
Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access
“Is Eptinezumab the Key to Reducing Chronic Migraine Disability?”
Sufyan Shahid, Minahil Iqbal
SN Comprehensive Clinical Medicine (2024) Vol. 6, Iss. 1
Closed Access
Sufyan Shahid, Minahil Iqbal
SN Comprehensive Clinical Medicine (2024) Vol. 6, Iss. 1
Closed Access
